Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

XOMA Corporation (XOMA)

  • Company Report
  • April 05, 2023, 15:32 UTC
  • 64

New SEC Form for XOMA Corporation

Comment Full text

Atossa Therapeutics Inc. (ATOS)

  • Company Report
  • April 04, 2023, 18:55 UTC
  • 67

Atossa Therapeutics SEC filing

Comment Full text

Alnylam Pharmaceuticals Inc (ALNY)

  • Company Report
  • April 03, 2023, 23:45 UTC
  • 63

New Form ARS for Alnylam Pharmaceuticals, Inc.

Comment Full text

Lumos Pharma Inc. (LUMO)

  • Company Report
  • April 03, 2023, 23:40 UTC
  • 67

New Form ARS for Lumos Pharma

Comment Full text

Corbus Pharmaceuticals Holdings Inc. (CRBP)

  • Company Report
  • April 03, 2023, 23:39 UTC
  • 63

New SEC Form for Corbus Pharmaceuticals Holdings, Inc.

Comment Full text

Supernus Pharmaceuticals Inc (SUPN)

  • Company Report
  • April 03, 2023, 23:24 UTC
  • 65

New Form 8-K for Supernus Pharmaceuticals

Comment Full text

Avantor Inc. (AVTR)

  • Company Report
  • April 03, 2023, 21:50 UTC
  • 67

Avantor - 2022 Annual Report

Comment Full text

Mustang Bio Inc (MBIO)

  • Company Report
  • April 03, 2023, 19:20 UTC
  • 62

Mustang Bio Announces Reverse Stock Split

Comment Full text

Biocept Inc. (BIOC)

  • Company Report
  • April 03, 2023, 15:10 UTC
  • 63

New Form NT 10-K for Biocept, Inc.

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Company Report
  • April 03, 2023, 14:20 UTC
  • 67

Moleculin Biotech, Inc. SEC filing

Comment Full text
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

Search

News categories

  • Technical Exchange News(9309)
  • Event(407)
  • SEC News(150123)
  • FDA Approval(8569)
  • Company Report(721)
  • Business News(103322)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin